fasting is one of the important religious practices of muslims, in which the individuals abstain from eating and drinking from dawn to sunset. fasting is not obligatory or even not allowed, in case it causes health problems to the fasting individual. rheumatic diseases are a major group of chronic diseases which can bring about numerous problems while fasting. the aim of this article is to revi...

Fasting is one of the important religious practices of Muslims, in which the individuals abstain from eating and drinking from dawn to sunset. Fasting is not obligatory or even not allowed, in case it causes health problems to the fasting individual. Rheumatic diseases are a major group of chronic diseases which can bring about numerous problems while fasting. The aim of this article is to revi...

background rheumatic diseases are chronic diseases, which may be associated with severe and debilitating pain. objectives the purpose of this study was to examine the prevalence of tobacco and opioid use among rheumatic patients. patients and methods in this cross-sectional study, 1042 patients referred to a major rheumatology clinic of kerman city, in south east of iran, were interviewed. pati...

background: osteonecrosis (on) is known to be one of the most disabling complications following corticosteroid (cs) medications. however, evidence regarding risk of asymptomatic prevalence of on among different diseases and the impact of variable steroid regimens are conflicting. we aimed to determine the prevalence of on of femoral head in asymptomatic patients with systemic rheumatic diseases...

how to cite this article: shiari r. neurologic manifestations of childhood rheumatic diseases.  iran j child neurol autumn 2012; 6(4): 1-7. children with rheumatic disorders may have a wide variety of clinical features ranging from fever or a simple arthritis to complex multisystem autoimmune diseases. information about the prevalence of neurological manifestations in children with rheumatologi...

The 12 previous volumes in this series are: 1999 – Combination DMARD therapy in rheumatoid arthritis 2000 – Bone mass in the rheumatic diseases 2001 – Controversies in COX-2 inhibitor therapy 2002 – Innovative therapies for spondyloarthritides 2003 – Early arthritis 2004 – Benefit/risk of new drugs for rheumatoid arthritis 2005 – Quantitative clinical assessment of rheumatic diseases 2006 – Rem...